Company Overview - Envista (NVST) is expected to report a year-over-year increase in earnings, with a consensus estimate of $0.24 per share, reflecting a change of +118.2% [3] - Revenues are anticipated to be $641.45 million, which is a 1.3% increase from the previous year [3] Earnings Expectations - The earnings report is scheduled for July 31, and the stock may rise if actual results exceed expectations, while a miss could lead to a decline [2] - The consensus EPS estimate has remained unchanged over the last 30 days, indicating stability in analyst expectations [4] Earnings Surprise Prediction - The Most Accurate Estimate for Envista is lower than the Zacks Consensus Estimate, resulting in an Earnings ESP of -2.65%, suggesting a bearish outlook from analysts [12] - Despite the negative Earnings ESP, Envista holds a Zacks Rank of 2, complicating predictions of an earnings beat [12] Historical Performance - In the last reported quarter, Envista exceeded the expected earnings of $0.20 per share, achieving $0.24, which was a surprise of +20.00% [13] - Over the past four quarters, Envista has beaten consensus EPS estimates three times [14] Industry Context - InMode (INMD), another player in the Zacks Medical - Products industry, is expected to post earnings of $0.43 per share, indicating a year-over-year change of +26.5% [18] - InMode's revenues are projected to be $95.5 million, up 10.5% from the previous year [18] - The consensus EPS estimate for InMode has been revised down by 9.8% over the last 30 days, and it currently has an Earnings ESP of 0% with a Zacks Rank of 5 [19]
Envista (NVST) Earnings Expected to Grow: Should You Buy?